Kadmon Holdings Inc
KDMN·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$9.50
Today
+0.0%
YTD
+0.0%
About
Kadmon is a New York-based healthcare company serving an international audience. Founded in 2010, the firm focuses on the development of treatments for inflammatory and fibrotic diseases. Kadmon is listed on the NYSE under the symbol KDMN. Keep up to date with the KDMN price chart by adding this instrument to your eToro watchlist.
Price chart
Closing price history for KDMN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-3.63
P/S (TTM)Unknown
P/B (TTM)4.85
Market cap$581.01M
Cap tierSmall-cap
Industry avg P/E-2.16
Profitability
Gross margin64.50%
EBIT margin-715.86%
Net margin-228.63%
ROE-379.15%
ROA-48.74%
Earnings & Revenue
Revenue (TTM)$16.08M
Revenue growth (1Y)+33.2%
EPS (TTM)-$0.71
Free cash flow$-102.90M
Total debt$249.97M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.07
Employees127
Next earnings3 Mar '22
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.